Literature DB >> 24304044

Support vector machines for drug discovery.

Kathrin Heikamp1, Jürgen Bajorath.   

Abstract

INTRODUCTION: Support vector machines (SVMs) are supervised machine learning algorithms for binary class label prediction and regression-based prediction of property values. In recent years, SVMs have become increasingly popular for drug discovery-relevant applications such as compound classification, the search for novel active compounds and property predictions. AREAS COVERED: The authors provide the readers with a brief introduction of SVM theory and discuss the kernel functions designed for drug discovery applications. The authors also review the different types of SVM applications in drug discovery, looking at particular case studies. Furthermore, the authors discuss the recent hybrid methods developed that incorporate SVM modeling in different ways. EXPERT OPINION: SVMs are currently among the best-performing approaches for chemical and biological property prediction and the computational identification of active compounds. It is anticipated that their use in drug discovery will further increase. Indeed, this will also include the development of SVM-based meta-classifiers that combine different approaches and exploit their individual strengths and complementarity.

Entities:  

Mesh:

Year:  2013        PMID: 24304044     DOI: 10.1517/17460441.2014.866943

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN: 1746-0441            Impact factor:   6.098


  23 in total

1.  Discovery of Influenza A virus neuraminidase inhibitors using support vector machine and Naïve Bayesian models.

Authors:  Wenwen Lian; Jiansong Fang; Chao Li; Xiaocong Pang; Ai-Lin Liu; Guan-Hua Du
Journal:  Mol Divers       Date:  2015-12-21       Impact factor: 2.943

2.  Sparse support vector machines with L0 approximation for ultra-high dimensional omics data.

Authors:  Zhenqiu Liu; David Elashoff; Steven Piantadosi
Journal:  Artif Intell Med       Date:  2019-04-30       Impact factor: 5.326

3.  Calculation of exact Shapley values for support vector machines with Tanimoto kernel enables model interpretation.

Authors:  Christian Feldmann; Jürgen Bajorath
Journal:  iScience       Date:  2022-08-27

4.  Evolution of Support Vector Machine and Regression Modeling in Chemoinformatics and Drug Discovery.

Authors:  Raquel Rodríguez-Pérez; Jürgen Bajorath
Journal:  J Comput Aided Mol Des       Date:  2022-03-19       Impact factor: 4.179

5.  Shallow Representation Learning via Kernel PCA Improves QSAR Modelability.

Authors:  Stefano E Rensi; Russ B Altman
Journal:  J Chem Inf Model       Date:  2017-08-07       Impact factor: 4.956

6.  Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.

Authors:  Kushagra Kashyap; Mohammad Imran Siddiqi
Journal:  Mol Divers       Date:  2021-07-19       Impact factor: 3.364

7.  Predicting Subtype Selectivity for Adenosine Receptor Ligands with Three-Dimensional Biologically Relevant Spectrum (BRS-3D).

Authors:  Song-Bing He; Zheng-Kun Kuang; Dong Wang; De-Xin Kong
Journal:  Sci Rep       Date:  2016-11-04       Impact factor: 4.379

8.  Prediction of selective estrogen receptor beta agonist using open data and machine learning approach.

Authors:  Ai-Qin Niu; Liang-Jun Xie; Hui Wang; Bing Zhu; Sheng-Qi Wang
Journal:  Drug Des Devel Ther       Date:  2016-07-18       Impact factor: 4.162

9.  Graph-based machine learning interprets and predicts diagnostic isomer-selective ion-molecule reactions in tandem mass spectrometry.

Authors:  Jonathan Fine; Judy Kuan-Yu Liu; Armen Beck; Kawthar Z Alzarieni; Xin Ma; Victoria M Boulos; Hilkka I Kenttämaa; Gaurav Chopra
Journal:  Chem Sci       Date:  2020-10-05       Impact factor: 9.825

10.  A Genetic Algorithm Based Support Vector Machine Model for Blood-Brain Barrier Penetration Prediction.

Authors:  Daqing Zhang; Jianfeng Xiao; Nannan Zhou; Mingyue Zheng; Xiaomin Luo; Hualiang Jiang; Kaixian Chen
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.